跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BROXIVAN 3 MG/ML SOLUCION ORAL EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BROXIVAN 3 MG/ML SOLUCION ORAL EFG
Approved
STANDARD
BROXIVAN 3 MG/ML SOLUCION ORAL EFG
Medochemie Iberia S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 9, 2021
Approval ID
a9e6b0934511c52c
Company
Medochemie Iberia S.A.
Type
Standard
Approval Details
Approval Id
a9e6b0934511c52c
Drug Cima Aemps Name
BROXIVAN 3 MG/ML SOLUCION ORAL EFG
Register Number
86434
Holder Company Name
Medochemie Iberia S.A.
Marketing Company Name
Medochemie Iberia S.A. Sucursal En Espana
Authorization Date
2021-12-09
Dosage Form
SOLUCIÓN ORAL
Dose
3 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Medochemie Iberia S.A.
Active Ingredients
AMBROXOL HIDROCLORURO
3 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 9, 2021
Approval ID
a9e6b0934511c52c
Type
Standard
Back to CIMA-AEMPS Approvals